Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  CEL-SCI Corporation    

 SummaryNewsCalendarCompanyFinancialsConsensus 
Company
CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases.The company's lead investigational therapy, Multikine, is being developed as a potential therapeutic agent... 
More about the company
Latest news on CEL-SCI CORPORATION
02/11 CEL SCI : Reports Monthly Patient Enrollment in January for Its Phase 3 Head and..
02/09 CEL SCI : posts 1Q profit
02/09 CEL SCI : NEW STORY CEL-SCI Corporation Reports First Quarter Fiscal 2016 Financ..
02/09 CEL SCI : Reports First Quarter Fiscal 2016 Financial Results
02/09 ERGOMED : CEL-SCI Reports First Quarter Fiscal 2016 Financial Results
02/08 CEL SCI : NEW STORY CEL-SCI To Present At Source Capital Group's 2016 Disruptive..
02/08 CEL SCI : To Present at Source Capital Group’s 2016 Disruptive Growth & He..
02/04 CEL-SCI CORPORATION : February Flaherty Financial Newsletter Features CEL-SCI Co..
More news
Sector news : Bio Therapeutic Drugs
02/12 AMGEN : Mystery cannabis 'consortium' reportedly interested in Longmont's Amgen ..
02/12 AMGEN : Kyprolis launches in the UK for relapsed multiple myeloma
02/11 ALNYLAM PHARMACEUTICALS : reports 4Q loss
More sector news : Bio Therapeutic Drugs
Comments 
Advertisement